ArticleMolecular and clinical oncology2018

Alternate-day administration of S-1 for elderly patients with advanced non-small-cell lung carcinoma: A prospective feasibility study.

Takeshi Masuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.